Terms: = Lung cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Clinical Outcome
5 results:
1. Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses.
Owonikoko TK; Niu H; Nackaerts K; Csoszi T; Ostoros G; Mark Z; Baik C; Joy AA; Chouaid C; Jaime JC; Kolek V; Majem M; Roubec J; Santos ES; Chiang AC; Speranza G; Belani CP; Chiappori A; Patel MR; Czebe K; Byers L; Bahamon B; Li C; Sheldon-Waniga E; Kong EF; Williams M; Badola S; Shin H; Bedford L; Ecsedy JA; Bryant M; Jones S; Simmons J; Leonard EJ; Ullmann CD; Spigel DR;
J Thorac Oncol; 2020 Feb; 15(2):274-287. PubMed ID: 31655296
[TBL] [Abstract] [Full Text] [Related]
2. Cooperation of DLC1 and cdk6 affects breast cancer clinical outcome.
Dai X; Li L; Liu X; Hu W; Yang Y; Bai Z
G3 (Bethesda); 2014 Nov; 5(1):81-91. PubMed ID: 25425654
[TBL] [Abstract] [Full Text] [Related]
3. [Clinicopathologic features of pleomorphic rhabdomyosarcoma].
Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):147-52. PubMed ID: 23769431
[TBL] [Abstract] [Full Text] [Related]
4. Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study.
Abdulkader I; Sánchez L; Cameselle-Teijeiro J; Gude F; Chávez JE; López-López R; Forteza J; Fraga M
Oncol Rep; 2005 Dec; 14(6):1527-31. PubMed ID: 16273250
[TBL] [Abstract] [Full Text] [Related]
5. Biological parameters on computed tomography guided fine needle aspiration biopsy from peripheral primary non-small cell lung cancer.
Bozzetti C; Nizzoli R; Guazzi A; Franciosi V; Cattelani L; Crafa P; Naldi N; Cascinu S
Lung Cancer; 2002 Mar; 35(3):243-7. PubMed ID: 11844597
[TBL] [Abstract] [Full Text] [Related]
